<bill session="108" type="h" number="896" updated="2023-01-15T22:03:57Z">
  <state datetime="2003-02-25">REFERRED</state>
  <status>
    <introduced datetime="2003-02-25"/>
  </status>
  <introduced datetime="2003-02-25"/>
  <titles>
    <title type="display">Breast Cancer Prescription Drug Fairness Act of 2003</title>
    <title type="official" as="introduced">To provide for substantial reductions in the price of prescription drugs for Medicare beneficiaries and for women diagnosed with breast cancer.</title>
    <title type="short" as="introduced">Breast Cancer Prescription Drug Fairness Act of 2003</title>
  </titles>
  <sponsor bioguide_id="M000309"/>
  <cosponsors>
    <cosponsor bioguide_id="A000014" joined="2003-03-18"/>
    <cosponsor bioguide_id="A000022" joined="2003-02-27"/>
    <cosponsor bioguide_id="B001245" joined="2003-03-13"/>
    <cosponsor bioguide_id="B001227" joined="2003-03-19"/>
    <cosponsor bioguide_id="C000191" joined="2003-03-27"/>
    <cosponsor bioguide_id="D000096" joined="2003-03-18"/>
    <cosponsor bioguide_id="D000399" joined="2003-03-04"/>
    <cosponsor bioguide_id="F000339" joined="2003-03-03"/>
    <cosponsor bioguide_id="F000392" joined="2003-03-03"/>
    <cosponsor bioguide_id="H000636" joined="2003-10-07"/>
    <cosponsor bioguide_id="I000057" joined="2003-03-03"/>
    <cosponsor bioguide_id="J000126" joined="2003-03-06"/>
    <cosponsor bioguide_id="K000172" joined="2003-03-03"/>
    <cosponsor bioguide_id="K000180" joined="2003-02-26"/>
    <cosponsor bioguide_id="L000551" joined="2003-06-03"/>
    <cosponsor bioguide_id="M000485" joined="2003-09-23"/>
    <cosponsor bioguide_id="M000590" joined="2003-02-26"/>
    <cosponsor bioguide_id="O000159" joined="2003-03-03"/>
    <cosponsor bioguide_id="P000149" joined="2003-02-26"/>
    <cosponsor bioguide_id="W000738" joined="2003-03-04"/>
  </cosponsors>
  <actions>
    <action datetime="2003-02-25">
      <text>Introduced in House</text>
    </action>
    <action datetime="2003-02-25" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2003-02-25">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2003-03-10">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2003-03-10">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSWM" name="House Ways and Means" subcommittee="" activity="Referral"/>
    <committee code="HSWM02" name="House Ways and Means" subcommittee="Health" activity="Referral"/>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Breast cancer"/>
    <term name="Commerce"/>
    <term name="Congress"/>
    <term name="Congressional reporting requirements"/>
    <term name="Drug industry"/>
    <term name="Drugs"/>
    <term name="Governmental investigations"/>
    <term name="Life expectancy"/>
    <term name="Medicare"/>
    <term name="Pharmacies"/>
    <term name="Prescription pricing"/>
    <term name="Price discrimination"/>
    <term name="Social Welfare"/>
    <term name="Terminal care"/>
    <term name="Terminally ill"/>
    <term name="Women"/>
    <term name="Women's health"/>
  </subjects>
  <amendments/>
  <summary date="2006-11-28T17:35:40Z" status="Introduced in House">Breast Cancer Prescription Drug Fairness Act of 2003 - Requires each participating manufacturer of a covered outpatient drug to make available for purchase by each pharmacy a covered outpatient drug: (1) in an amount equal to the aggregate amount of the covered outpatient drug sold or distributed by the pharmacy to Medicare beneficiaries (including the amount sold or distributed to Medicare beneficiaries in a hospice program); and (2) at a price equal to the lower of either the lowest price paid for the drug by the Federal Government or the manufacturer's best price for the drug.</summary>
</bill>
